How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

2009 ◽  
Vol 24 (4) ◽  
pp. 269-275 ◽  
Author(s):  
David S. Baldwin ◽  
Dan J. Stein ◽  
Ornah T. Dolberg ◽  
Borwin Bandelow
2019 ◽  
Vol 243 ◽  
pp. 531-538 ◽  
Author(s):  
Julia K. Langer ◽  
Natasha A. Tonge ◽  
Marilyn Piccirillo ◽  
Thomas L. Rodebaugh ◽  
Renee J. Thompson ◽  
...  

1997 ◽  
Vol 171 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Christine Scott ◽  
Mary Jane Tacchi ◽  
Roger Jones ◽  
Jan Scott

BackgroundThe consensus statement on the treatment of depression (Paykel & Priest, 1992) advocates the use of cognitive therapy techniques as an adjunct to medication.MethodThis paper describes a randomised controlled trial of brief cognitive therapy (BCT) plus ‘treatment as usual’ versus treatment as usual in the management of 48 patients with major depressive disorder presenting in primary care.ResultsAt the end of the acute phase, significantly more subjects (P < 0.05) met recovery criteria in the intervention group (n=15) compared with the control group (n=8). When initial neuroticism scores were controlled for, reductions in Beck Depression Inventory and Hamilton Rating Scale for Depression scores favoured the BCT group throughout the 12 months of follow-up.ConclusionsBCT may be beneficial, but given the time constraints, therapists need to be more rather than less skilled in cognitive therapy. This, plus methodological limitations, leads us to advise caution before applying this approach more widely in primary care.


Sign in / Sign up

Export Citation Format

Share Document